| Name | JNJ-4355 | 
|---|
| Description | JNJ-4355 is a highly potent MCL-1 (myeloid cell leukemia-1) inhibitor, with KI of 18 pM. JNJ-4355 shows antitumor activity[1][2]. | 
|---|---|
| Related Catalog | |
| Target | Mcl-1:18 pM (Ki) | 
| In Vitro | JNJ-4355 shows promising in vitro potency data in cancer cell lines and AML patient-derived samples[2]. | 
| In Vivo | JNJ-4355 (IV , single) shows complete tumor regression in a mouse MOLP8 (multiple myeloma) xenograft[2]. | 
| References | 
| Molecular Formula | C40H43ClFN5O5S | 
|---|---|
| Molecular Weight | 760.32 |